Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08ZBT
|
||||
| Former ID |
DIB015536
|
||||
| Drug Name |
SDZ-WAG-994
|
||||
| Synonyms |
WAG-994
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Discontinued in Phase 1 | [545500] | ||
| Company |
Novartis AG
|
||||
| Formula |
C17H25N5O4
|
||||
| Canonical SMILES |
n1([C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)OC)c2c(nc1)c(ncn2)<br />NC1CCCCC1
|
||||
| CAS Number |
CAS 130714-47-5
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A1 receptor | Target Info | Agonist | [533841] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| RANKL Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.